Radiation Oncology

Radiation therapy uses high-energy radiation to damage cancer cells' DNA and destroy their ability to divide and grow. It is delivered using linear accelerators, proton accelerators, metered cobalt-60 exposure, or brachytherapy where radioactive seeds are placed inside the patient on a temporary or permanent basis to kill cancer or relieve pain. The main radiation oncology society and annual conference is the American Society of Radiation Oncology (ASTRO).

Imaging may be misleading when determining the success of cancer treatment
A new analysis calls into question the use of imaging alone to determine the efficacy of ablative radiation therapy.
Prostate cancer radiotherapy timeline can be safely shortened
Isodose moderately hypofractionated radiotherapy allows patients to undergo just 4-5 weeks of treatment, compared to conventional therapy that can take around 8.
Simple CT metric predicts treatment-induced kidney impairment in prostate cancer patients
Though effective, Lu-177 radioligland therapy is not without side effects, some of which can be severe.
Tiny 'water bears' may hold key to reducing radiation-induced side effects
These animals are virtually indestructible and have long outlived the dinosaurs due to their ability to withstand extreme cold, heat, natural disasters and even cosmic radiation.
Orano Med breaks ground on $265M thorium production site
The new 7,000-square-meter plant is located in France and will begin production of thorium-228, necessary for the development of isotopes used in cancer treatments.

FUJIFILM ANNOUNCES ENTRY INTO U.S. COMPUTED TOMOGRAPHY MARKET WITH UNVEILING OF FCT EMBRACE AT ASTRO 2018

STAMFORD, Conn.—FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, today introduced the FCT Embrace. Powered by Analogic, the FCT Embrace is the world’s first 85cm wide bore computed tomography (CT) imaging unitwith 64 or 128 slice configurations. Optimized for both oncology and radiology applications, the FCT Embrace, combined with other market-leading oncology solutions, offers enhanced and efficient CT Simulation with radiotherapy treatment planning capabilities. The unveiling at booth #3063 during the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting marks Fujifilm’s entry into the CT market, expanding its end-to-end diagnostic imaging product portfolio which is recognized for exceptional imaging at low dose.

ASTRO, industry leaders issue new radiation treatment guidelines for early-stage prostate cancer

Prominent medical societies have issued new clinical guidelines, Thursday, Oct. 11, recommending physicians use external beam radiation therapy (EBRT) to treat men with early-stage prostate cancer.

Radiation Oncology

Imaging may be misleading when determining the success of cancer treatment

Prostate cancer radiotherapy timeline can be safely shortened

Simple CT metric predicts treatment-induced kidney impairment in prostate cancer patients

Tiny 'water bears' may hold key to reducing radiation-induced side effects

Orano Med breaks ground on $265M thorium production site